RaymondPSnyderMD

PubMed

• 3 citations
  Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical setting.
  Belinda Lee, Ben Tran, Arthur Hsu, Graham R. Taylor, Stephen B. Fox, Andrew Fellowes, Renata Marquis, Jennifer Mooi, Jayesh Desai, Ken Doig, Paul G Ekert, Clara Gaff, ...> ;Internal Medicine Journal. 2018 Jul 1
• The utility of routine pre-chemotherapy screening with cardiac gated blood pool scan for patients at low risk of anthracycline toxicity.
  Puey Ling Chia, K Chiang, Raymond Snyder, Anthony Dowling> ;Journal of Oncology Pharmacy Practice. 2018 Jun 1
• 4 citations
  A Randomized Controlled Trial of an Additional Funding Intervention to Improve Clinical Trial Enrollment.
  Catriona Parker, Raymond Snyder, Michael Jefford, David M. Dilts, Rory Wolfe, Jeremy Millar> ;Journal of the National Comprehensive Cancer Network. 2017 Sep 1
• 16 citations
  Systemic treatment of HER2-positive metastatic breast cancer: a systematic review.
  Nicholas Wilcken, Nicholas Zdenkowski, Michelle White, Raymond Snyder, Ken Pittman, Paul N. Mainwaring, Michael D. Green, Prudence A. Francis, Richard De Boer, Maree C...> ;Asia-Pacific Journal of Clinical Oncology. 2014 Jun 1
• 226 citations
  Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII...
  Otto Metzger-Filho, Zhuoxin Sun, Giuseppe Viale, Karen N. Price, Diana Crivellari, Raymond Snyder, Richard D. Gelber, M. Castiglione-Gertsch, Alan S. Coates, Aron Gold...> ;Journal of Clinical Oncology. 2013 Sep 1
• 29 citations
  Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study.
  David M. Hyams, Arlene Chan, Celia de Oliveira, Raymond Snyder, Jeferson Vinholes, M. William Audeh, Victor M. Alencar, Janine Lombard, Bijoyesh Mookerjee, John Xu, Ka...> ;Investigational New Drugs. 2013 Jun 26
• 2 citations
  A retrospective cohort study of metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy, with an exploratory analysis of changing serum carci...
  Say Liang Ng, W. I. Burns, Raymond Snyder, Genni M Newnham, Sue-Anne McLachlan, Danny Liew, Anthony Dowling> ;Asia-Pacific Journal of Clinical Oncology. 2012 Jan 12
• 44 citations
  Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX
  S. Aebi, Zhuoxin Sun, Danielle Braun, Karen N. Price, M. Castiglione-Gertsch, Manuela Rabaglio, Richard D. Gelber, Diana Crivellari, J. Lindtner, Raymond Snyder, Per K...> ;Annals of Oncology. 2011 Sep 1
• 9 citations
  Rational use of trastuzumab in metastatic and locally advanced breast cancer: implications of recent research
  Shom Goel, Jacquie Chirgwin, Prudence A. Francis, Robin Stuart-Harris, J. Dewar, Linda Mileshkin, Raymond Snyder, Michael Michael, Bogda Koczwara> ;Breast. 2011 Apr 1
• 66 citations
  Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase ...
  Miguel Martin, Henri Roché, Tamás Pintér, John Crown, M. John Kennedy, Louise Provencher, Frank Priou, Wolfgang Eiermann, Encarna Adrover, István Láng, Manuel Ramos, J...> ;The Lancet. Oncology. 2011 Apr 1
• 48 citations
  Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer
  Michael D. Green, Prudence A. Francis, Val Gebski, Vernon Harvey, Christos S. Karapetis, Arlene Chan, Raymond Snyder, A. Fong, Russell L. Basser, John F. Forbes> ;Annals of Oncology. 2009 Nov 1
• 318 citations
  Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials
  Bernhard C. Pestalozzi, David Zahrieh, Elizabeth Mallon, Barry A. Gusterson, Karen N. Price, Richard D. Gelber, Stig Holmberg, Jurij Lindtner, Raymond Snyder, Beat Thü...> ;Journal of Clinical Oncology. 2008 Jun 20
• 11 citations
  Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group.
  Lorenzo Gianni, Bernard F. Cole, Ilaria Panzini, Raymond Snyder, Stig Holmberg, M. J. Byrne, Diana Crivellari, Marco Colleoni, S. Aebi, Edda Simoncini, Olivia Pagani, ...> ;Supportive Care in Cancer. 2008 Jan 1
• 214 citations
  Supportive‐expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial
  David W. Kissane, Brenda Grabsch, David M Clarke, Graeme C. Smith, Anthony W. Love, Sidney Bloch, Raymond Snyder, Yuelin Li> ;Psycho-Oncology. 2007 Apr 1
• 43 citations
  Information from the Internet: attitudes of Australian oncology patients
  Genni M Newnham, W. I. Burns, Raymond Snyder, Anthony Dowling, Nadia F Ranieri, E. L. Gray, Sue-Anne McLachlan> ;Internal Medicine Journal. 2006 Nov 1
• 87 citations
  Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey.
  Brenda Grabsch, David M Clarke, Anthony W. Love, Dean Philip McKenzie, Raymond Snyder, Sidney Bloch, Graeme C. Smith, David W. Kissane> ;Palliative & Supportive Care. 2006 Mar 1
• 15 citations
  Reducing the global breast cancer burden: the importance of patterns of care research.
  Kathy S. Albain, Jaime de la Garza Salazar, Tadeusz Pienkowski, Matti Aapro, Jonas Bergh, Maira Caleffi, Robert E. Coleman, Wolfgang Eiermann, Fikri Icli, Mark D. Pegr...> ;Clinical Breast Cancer. 2005 Dec 1
• 38 citations
  Attitudes of oncology health professionals to information from the Internet and other media.
  Genni M Newnham, W. Ivon Burns, Raymond Snyder, Anthony Dowling, Nadia F Ranieri, Emma L Gray, Sue-Anne McLachlan> ;The Medical Journal of Australia. 2005 Aug 15
• 1110 citations
  Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastat...
  M Marty, Francesco Cognetti, Dominique Maraninchi, Raymond Snyder, Louis Mauriac, Michèle Tubiana-Hulin, Stephen Chan, David Grimes, Antonio Antón, Anna Lluch, John Ke...> ;Journal of Clinical Oncology. 2005 Jul 1
• 64 citations
  Site of Primary Tumor Has a Prognostic Role in Operable Breast Cancer: The International Breast Cancer Study Group Experience
  Marco Colleoni, David Zahrieh, Richard D. Gelber, Stig Holmberg, Jan E Mattsson, C. M. Rudenstam, Jurij Lindtner, Darja Erzen, Raymond Snyder, John P. Collins, Martin ...> ;Journal of Clinical Oncology. 2005 Mar 1
• 22 citations
  Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast ...
  Juerg Bernhard, David Zahrieh, Alan S. Coates, Richard D. Gelber, M. Castiglione-Gertsch, Elizabeth Murray, John F. Forbes, Lucien Perey, John P. Collins, Raymond Snyd...> ;British Journal of Cancer. 2004 Nov 23
• 89 citations
  Effect of Cognitive-Existential Group Therapy on Survival in Early-Stage Breast Cancer
  David W. Kissane, Anthony W. Love, Allison Hatton, Sidney Bloch, Graeme C. Smith, David M Clarke, Patricia Miach, Jill Ikin, Nadia F Ranieri, Raymond Snyder> ;Journal of Clinical Oncology. 2004 Nov 1
• 205 citations
  Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
  Gilles Berclaz, S. Li, Karen N. Price, Alan S. Coates, M. Castiglione-Gertsch, C.-M. Rudenstam, Stig Holmberg, J. Lindtner, D. Erien, John P. Collins, Raymond Snyder, ...> ;Annals of Oncology. 2004 Jun 1
• 5 citations
  New concepts in breast cancer therapy
  Raymond Snyder> ;Internal Medicine Journal. 2004 May 1
• 1 citations
  Nephrotic syndrome associated with carcinoma of the breast.
  P A Hill, D G Goodman, Raymond Snyder> ;Clinical Nephrology. 2003 Dec 1
• Join now to see all